Herpes simplex virus type 1 impairs mucosal-associated invariant T cells
mBio · 14.05.2025 · 16 (5)
DOI: 10.1128/mbio.03887-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 14.05.2025. Verfasst von Lauren Stern und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Mucosal-Associated Invariant T Cells, Herpes Simplex. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DHAC | National Health and Medical Research Council (NHMRC), HHS | National Institutes of Health (NIH), Department of Education and Training | Australian Research Council (ARC).
Abstract (Originalsprache)
Herpes simplex virus type 1 (HSV-1) is a highly successful pathogen that infects mucosal sites and adopts an arsenal of strategies to manipulate host immunity. Mucosal-associated invariant T (MAIT) cells are abundant innate-like T lymphocytes that recognize bacterial and fungal-derived vitamin B-related metabolites presented by major histocompatibility complex class I-related protein 1 (MR1). MAIT cells can also be activated in an MR1-independent manner via cytokine stimulation, predominantly by IL-12 and IL-18. MAIT cell alterations have been identified as being associated with a number of viral infections, but direct interactions between viruses and MAIT cells are poorly understood. It is unknown whether HSV-1 can infect MAIT cells and modulate their functions. Here, we show that HSV-1 can infect primary human MAIT cells, including CD4 ± /CD8 ± and CD56 ± MAIT cell subpopulations. Furthermore, HSV-1 infection profoundly inhibits the functional capacity of MAIT cells to respond to T cell receptor (TCR)-dependent stimulation by the MAIT cell activating ligand 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU) and to cytokine stimulation by IL-12/IL-18. HSV-1-infected MAIT cells display reduced cytotoxic potential, diminished synthesis of effector cytokines, and decreased expression of key cytokine receptors including IL-18R. In addition, MAIT cells exposed to HSV-1-infected fibroblasts but which remained uninfected (viral GFP-negative) also exhibit a suppressed effector response to TCR-dependent stimulation. The functional suppression of HSV-1-exposed MAIT cells was not mediated by a soluble factor within the supernatant, suggesting direct contact of MAIT cells with HSV-1-infected fibroblasts is required. Overall, this study reveals that HSV-1 can infect MAIT cells and substantially impair MAIT cell effector functions. IMPORTANCE Mucosal-associated invariant T cells (MAIT cells) are “unconventional” immune cells that are becoming increasingly appreciated to play important roles in a variety of viral infections. Herpes simplex virus (HSV) causes significant human disease and is a master manipulator of multiple immune functions, but how this virus may control MAIT cells is poorly understood. We discovered that HSV can infect human MAIT cells and impair their functional capacity and also show that MAIT cells exposed to HSV, but which do not show evidence of infection, are similarly impaired. This study therefore identifies an additional immunomodulatory function of HSV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
- ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
- John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
- Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
ORCID-Profile: Lauren Stern, Carolyn Samer, David P Fairlie, David C Tscharke, Alexandra J Corbett, Allison Abendroth, Barry Slobedman
Förderung
- DHAC | National Health and Medical Research Council (NHMRC)
- HHS | National Institutes of Health (NIH)
- Department of Education and Training | Australian Research Council (ARC)
- NIAID NIH HHS
- Dame Kate Campbell Fellowship
Zitieren
APA
Stern, L., Emanuel, Z., Traves, R., Willis, K., Purohit, S. K., Samer, C., Mak, J. Y. W., Fairlie, D. P., Tscharke, D. C., Corbett, A. J., Abendroth, A., & Slobedman, B. (2025). Herpes simplex virus type 1 impairs mucosal-associated invariant T cells. mBio, 16(5). https://doi.org/10.1128/mbio.03887-24
Vancouver
Stern L, Emanuel Z, Traves R, Willis K, Purohit SK, Samer C, et al. Herpes simplex virus type 1 impairs mucosal-associated invariant T cells. mBio. 2025;16(5). doi:10.1128/mbio.03887-24
BibTeX
@article{Stern2025,
author = {Stern, Lauren and Emanuel, Zoe and Traves, Renee and Willis, Katherine and Purohit, Shivam K and Samer, Carolyn and Mak, Jeffrey Y W and Fairlie, David P and Tscharke, David C and Corbett, Alexandra J and Abendroth, Allison and Slobedman, Barry},
title = {Herpes simplex virus type 1 impairs mucosal-associated invariant T cells},
journal = {mBio},
year = {2025},
volume = {16},
number = {5},
doi = {10.1128/mbio.03887-24}
}
EUVIMED